Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation

Xiaoyun Tang(University of Alberta), David N. Brindley(University of Alberta)
Molecular Cancer
February 8, 2017
Cited by 54


Related Papers